Chubb, D., Weinhold, N., Broderick, P., Chen, B., Johnson, D., Försti, A., Vijayakrishnan, J., Migliorini, G., Dobbins, S., Holroyd, A., Hose, D., Walker, B., Davies, F., Gregory, W., Jackson, G., Irving, J., Pratt, G., Fegan, Christopher Daniel ![]() |
Official URL: http://dx.doi.org/10.1038/ng.2733
Abstract
To identify variants for multiple myeloma risk, we conducted a genome-wide association study with validation in additional series totaling 4,692 individuals with multiple myeloma (cases) and 10,990 controls. We identified four risk loci at 3q26.2 (rs10936599, P = 8.70 × 10 -14), 6p21.33 (rs2285803, PSORS1C2, P = 9.67 × 10 -11), 17p11.2 (rs4273077, TNFRSF13B, P = 7.67 × 10 -9) and 22q13.1 (rs877529, CBX7, P = 7.63 × 10 -16). These data provide further evidence for genetic susceptibility to this B-cell hematological malignancy, as well as insight into the biological basis of predisposition.
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Medicine |
Subjects: | R Medicine > R Medicine (General) R Medicine > RZ Other systems of medicine |
Uncontrolled Keywords: | Case-Control Studies; Chromosome Aberrations; Chromosomes, Human; Genetic Predisposition to Disease; Humans; Multiple Myeloma |
Publisher: | Nature Publishing Group |
ISSN: | 1061-4036 |
Last Modified: | 28 Oct 2022 09:47 |
URI: | https://orca.cardiff.ac.uk/id/eprint/75705 |
Citation Data
Cited 127 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
![]() |
Edit Item |